IM Cannabis Corp. (IMCC.CN)
CAD 2.75
(-8.33%)
CAD 2.75
(-8.33%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 13.78 Million CAD | 19.49% |
| 2022 | 11.53 Million CAD | -60.59% |
| 2021 | 29.26 Million USD | 2856.36% |
| 2020 | 990 Thousand CAD | -5.71% |
| 2019 | 1.05 Million CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | -100.0% |
| 2016 | 6441.00 CAD | 8.42% |
| 2015 | 5941.00 CAD | 18.82% |
| 2014 | 5000.00 CAD | -82.76% |
| 2013 | 29 Thousand CAD | -3.33% |
| 2012 | 30 Thousand CAD | -85.0% |
| 2011 | 200 Thousand CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| 2005 | - CAD | 0.0% |
| 2004 | - CAD | 0.0% |
| 2003 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 13.54 Million CAD | -1.71% |
| 2024 Q2 | 15.74 Million CAD | 16.2% |
| 2023 FY | 13.78 Million CAD | 19.49% |
| 2023 Q1 | 10.01 Million CAD | -13.16% |
| 2023 Q3 | 11.68 Million CAD | -12.05% |
| 2023 Q2 | 13.28 Million CAD | 32.61% |
| 2023 Q4 | 13.78 Million CAD | 17.99% |
| 2022 Q3 | 7.75 Million CAD | -78.47% |
| 2022 FY | 11.53 Million CAD | -60.59% |
| 2022 Q1 | 34.73 Million CAD | 18.67% |
| 2022 Q4 | 11.53 Million CAD | 48.71% |
| 2022 Q2 | 36.02 Million CAD | 3.72% |
| 2021 Q2 | 14.94 Million CAD | 23.08% |
| 2021 Q1 | 12.14 Million CAD | 1126.77% |
| 2021 Q3 | 24.35 Million CAD | 62.9% |
| 2021 Q4 | 29.26 Million USD | 20.2% |
| 2021 FY | 29.26 Million USD | 2856.36% |
| 2020 Q1 | 1.13 Million CAD | 27.38% |
| 2020 Q3 | 1.01 Million CAD | -4.23% |
| 2020 FY | 990 Thousand CAD | -5.71% |
| 2020 Q4 | 990 Thousand CAD | -2.75% |
| 2020 Q2 | 1.06 Million CAD | -6.34% |
| 2019 Q4 | 891 Thousand CAD | 2.18% |
| 2019 Q2 | 873 Thousand CAD | -51.36% |
| 2019 FY | 1.05 Million CAD | 0.0% |
| 2019 Q3 | 872 Thousand CAD | -0.11% |
| 2019 Q1 | 1.79 Million CAD | 3490.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q4 | 50 Thousand CAD | 0.0% |
| 2018 Q1 | - CAD | -100.0% |
| 2017 Q1 | 6441.00 CAD | 0.0% |
| 2017 FY | - CAD | -100.0% |
| 2017 Q4 | 31.81 Thousand CAD | 0.68% |
| 2017 Q3 | 31.6 Thousand CAD | 378.67% |
| 2017 Q2 | 6602.00 CAD | 2.5% |
| 2016 FY | 6441.00 CAD | 8.42% |
| 2015 FY | 5941.00 CAD | 18.82% |
| 2014 Q1 | 29 Thousand CAD | 262.5% |
| 2014 Q2 | 55.5 Thousand CAD | 91.38% |
| 2014 FY | 5000.00 CAD | -82.76% |
| 2014 Q3 | 77.5 Thousand CAD | 39.64% |
| 2014 Q4 | 5000.00 CAD | -93.55% |
| 2013 Q4 | 8000.00 CAD | 0.0% |
| 2013 Q3 | - CAD | -100.0% |
| 2013 Q2 | 30 Thousand CAD | 0.0% |
| 2013 Q1 | 30 Thousand CAD | 0.0% |
| 2013 FY | 29 Thousand CAD | -3.33% |
| 2012 FY | 30 Thousand CAD | -85.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q2 | - CAD | -100.0% |
| 2012 Q1 | 200 Thousand CAD | 0.0% |
| 2011 FY | 200 Thousand CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| 2006 Q2 | - CAD | 0.0% |
| 2006 Q1 | - CAD | 0.0% |
| 2006 Q3 | - CAD | 0.0% |
| 2006 Q4 | - CAD | 0.0% |
| 2005 Q4 | - CAD | 0.0% |
| 2005 Q2 | - CAD | 0.0% |
| 2005 Q1 | - CAD | 0.0% |
| 2005 Q3 | - CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| 2004 FY | - CAD | 0.0% |
| 2004 Q2 | - CAD | 0.0% |
| 2004 Q3 | - CAD | 0.0% |
| 2004 Q4 | - CAD | 0.0% |
| 2004 Q1 | - CAD | 0.0% |
| 2003 Q3 | - CAD | -100.0% |
| 2003 Q2 | 175 Thousand CAD | 0.0% |
| 2003 FY | - CAD | 0.0% |
| 2003 Q4 | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aion Therapeutic Inc. | 826.47 Thousand CAD | -1567.574% |
| Ayurcann Holdings Corp. | 709.07 Thousand CAD | -1843.67% |
| Blueberries Medical Corp. | 12.8 Thousand CAD | -107538.238% |
| The BC Bud Corporation | 229.35 Thousand CAD | -5909.025% |
| BioNxt Solutions Inc. | 4.89 Million CAD | -181.601% |
| CordovaCann Corp. | 6.37 Million CAD | -116.039% |
| Christina Lake Cannabis Corp. | 6.09 Million CAD | -126.078% |
| Captor Capital Corp. | 6.71 Million CAD | -105.242% |
| City View Green Holdings Inc. | 1.49 Million CAD | -819.677% |
| 1CM Inc. | 6.39 Million CAD | -115.539% |
| Global Hemp Group Inc. | 3.55 Million CAD | -287.502% |
| Greenway Greenhouse Cannabis Corporation | 16.02 Million CAD | 13.972% |
| Lobe Sciences Ltd. | 332.64 Thousand CAD | -4043.218% |
| Maple Leaf Green World Inc. | 2.47 Million CAD | -456.81% |
| Mountain Valley MD Holdings Inc. | - CAD | -Infinity% |
| Nextleaf Solutions Ltd. | 449.74 Thousand CAD | -2964.396% |
| Ovation Science Inc. | 192.61 Thousand CAD | -7055.206% |
| Pharmadrug Inc. | 1.76 Million CAD | -680.045% |
| Captiva Verde Wellness Corp. | 191.7 Thousand CAD | -7089.208% |
| RAMM Pharma Corp. | 405.14 Thousand CAD | -3301.787% |
| RIV Capital Inc. | 6.59 Million CAD | -109.04% |
| Revive Therapeutics Ltd. | 25.21 Thousand CAD | -54555.774% |
| Red White & Bloom Brands Inc. | 262.13 Million CAD | 94.742% |
| SLANG Worldwide Inc. | 29.86 Million CAD | 53.856% |
| 1933 Industries Inc. | 17.57 Million CAD | 21.564% |
| Red Light Holland Corp. | 811.04 Thousand CAD | -1599.285% |
| Top Strike Resources Corp. | 13.29 Million CAD | -3.7% |
| Xebra Brands Ltd. | - CAD | -Infinity% |
| Adastra Holdings Ltd. | 3.58 Million CAD | -284.62% |